105
Participants
Start Date
March 25, 2009
Primary Completion Date
October 18, 2012
Study Completion Date
October 18, 2012
UK-453,061 Dose 1
UK 453,061 750 mg QD + one optimized NRTI + darunavir/ritonavir.
UK-453,061 Dose 2
UK 453,061 1000 mg QD + one optimized NRTI + darunavir/ritonavir.
Etravirine
Etravirine 200 mg BID + one optimized NRTI + darunavir/ritonavir.
Soweto Clinical Trials Centre, Johannesburg
Chris Hani Baragwanath Hospital, Soweto
University of Witwatersrand, Johannesburg
Dr. J Fourie Medical Centre, Dundee
203 Maxwell Centre, Durban
Willowmead Medical Center, Cape Town
Desmond Tutu HIV Foundation, Cape Town
Greiger Clinic, Mount Vernon
Nassau University Medical Center, East Meadow
Hospital Raja Perempuan Zainab II, Kota Bharu
Vinnitsa Regional center for AIDS Prevention and Control, Berezyna
Hospital Universitario La Paz, Madrid
Rosedale Infectious Diseases, Huntersville
AIDS Research Consortium of Atlanta, Atlanta
Infectious Diseases Associates of Northwest Florida, PA, Pensacola
Orlando Immunology Center, Orlando
The Kinder Medical Group, Miami
Care Resource, Miami
Hillsborough County Health Department, Tampa
Unita' Operativa Malattie Infettive, Bologna
Klinikum der Universitaet zu Koeln, Klinik I fuer Innere Medizin, Cologne
University Malaya Medical Centre, Kuala Lumpur
Ruth M. Rothstein CORE Center, Chicago
Nicholaos C. Bellos, MD, PA, Dallas
University of Texas Southwestern Medical Center at Dallas, Dallas
Saint Hope Foundation - Conroe Clinic, Conroe
Saint Hope Foundation - Bellaire Clinic, Bellaire
Saint Hope Foundation - Stafford Clinic, Stafford
Department of Infectious Disease, E-Da Hospital, Kaohsiung County
Donetsk Regional Center of AIDSs prophylaxis and control, Donetsk
Jeffrey Goodman Special Care Clinic, Los Angeles
Office of Anthony Mills, MD, Inc., Los Angeles
Lugansk Regional Center of AIDS prophylaxis and control, Luhansk
San Francisco Veterans Affairs Medical Center, San Francisco
CARES, Sacramento
University of California Davis Medical Center, Sacramento
University of Cincinnati Medical Center, Cincinnati
Instituto A.Z. de Pesquisa e Ensino, Curitiba
Hospital Geral de Nova Iguacu, Nova Iguaçu
Hospital Nossa Senhora da Conceicao, Porto Alegre
Instituto de Infectologia Campinas, Campinas
Centro de Referencia e Treinamento DST/AIDS, São Paulo
Hospital Heliopolis, São Paulo
U.O.S. Immunologia Clinica, Roma
Oddzial do Leczenia HIV, Szczecin
SPZOZ Wojewodzki Szpital Zakazny, Warsaw
Hospitais da Universidade de Coimbra, Coimbra
Centro Hospitalar de Lisboa - Zona Central - Hospital Santo António Capuchos, Lisbon
Centro Hospitalar de Lisboa Ocidental, EPE., Lisbon
Hospital São João, Porto
Hospital de Joaquim Urbano, Porto
UPR-CTU Pharmacy, San Juan
University of Puerto Rico - Medical Sciences Campus - Puerto Rico Medical Center, Rio Piedras
Innovative Care PSC, Bayamón
Ararat Research Center, Ponce
HOPE Clinical Research, San Juan
Hospital Universitari Germans Trias I Pujol, Badalona
Veterans General Hospital - Taipei, Taipei
Brighton and Sussex University Hospitals NHS Trust, Brighton
North Manchester General Hospital, Crumpsall
Royal Infirmary GUM Clinic, Edinburgh
Western General Hospital, Edinburgh
Royal Free Hospital, London
Lead Sponsor
Pfizer
INDUSTRY